The present stock price for Mineralys Therapeutics Inc (MLYS) is $14.61. In the last trading session, the stock made a considerable jump, reaching $48.0 after an opening price of $14.61. The stock briefly fell to $15.0 before ending the session at $15.48.
Mineralys Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $18.38 on 03/19/25 and a low of $8.24 for the same time frame on 02/25/25.
52-week price history of MLYS Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Mineralys Therapeutics Inc’s current trading price is -20.51% away from its 52-week high, while its distance from the 52-week low is 77.28%. The stock’s price range during the 52-week period has remained between $8.24 and $18.38. In the Healthcare sector, the company’s shares saw a trading volume of around 0.86 million for the day, which was evidently higher than the average daily volume of 0.79 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Mineralys Therapeutics Inc (MLYS) has experienced a quarterly decline of -12.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 968.57M and boasts a workforce of 51 employees.
A Closer Look at Analysts’ Ratings for Mineralys Therapeutics Inc
As of right now, 7 analysts are rating Mineralys Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.34, with a change in price of -0.05. Similarly, Mineralys Therapeutics Inc recorded 873,683 in trading volume during the last 100 days, posting a change of -0.34%.
MLYS Stock Stochastic Average
Mineralys Therapeutics Inc’s raw stochastic average for the past 50 days is presently 56.42%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 68.24%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 76.46% and 79.47%, respectively.
MLYS Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 37.57% this year. Over the last six months, there has been a weaker performance of 53.31%. The price of MLYS fallen by 9.77% during the last 30 days period. For the last 5-days stocks have improved 3.40%.
